Please assess the completion status of the following clinical trial:

Trial Title: Patient Registry Study of Berinert® in Normal Clinical Practice

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Any patient receiving CSL Behring's C1-esterase inhibitor~* Written informed consent (may not be required for some retrospective chart review cases)~Exclusion Criteria:~* Any patient participating in an HAE study using other C1-inhibitors than Berinert®

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Berinert (Type: None): Patients requiring treatment with Berinert®

Based on this trial design, predict the completion outcome and termination type (if applicable).